Uploaded July 2021 | Updated September 2026, 2 weeks ago
About the Event
everythingals.org/event-details/braingate-toward-the-restoration-of-communication-and-mobility-for-people-with-als
We are excited to host EverythingALS Community Event: BrainGate: Toward the restoration of communication and mobility for people with ALS.
Our speaker Dr. Leigh R. Hochberg, Neurologist at MGH and directs Center for Neurotechnology and Neurorecovery at MGH. He is joined by Dr. Daniel Ruben, Neurologist of MGH and one of the investigators for the BrainGate Clinical Trial.
Leigh R. Hochberg, MD, PhD is Professor of Engineering, School of Engineering and Carney Institute for Brain Science, Brown University; Director, VA RR&D Center for Neurorestoration and Neurotechnology (CfNN), Providence VAMC; Neurologist at Massachusetts General Hospital, where he attends in the NeuroICU and on the Acute Stroke service; and Senior Lecturer on Neurology at Harvard Medical School. He also directs the Center for Neurotechnology and Neurorecovery at MGH, and is the IDE Sponsor-Investigator and Principal Investigator of the BrainGate clinical trials, conducted by a close collaboration of scientists and clinicians at Brown, Case Western Reserve, MGH, Providence VAMC, and Stanford. Dr. Hochberg’s research focuses on the development and testing of novel neurotechnologies to help people with paralysis and other neurologic disorders. Dr. Hochberg and his research with the collaborative BrainGate team have been honored with the Joseph Martin Prize in Basic Research, the Herbert Pardes Prize for Excellence in Clinical Research, the first Israel Brain Technologies international B.R.A.I.N. Prize, presented by President Shimon Peres, and the Derek Denny-Brown Young Neurological Scholar Award. Dr. Hochberg’s BrainGate research, which has been published Nature, Lancet, Science Translational Medicine, eLife, Nature Medicine, Nature Neuroscience, the Journal of Neuroscience, the Journal of Neural Engineering, and others, is supported by the Rehabilitation R&D Service of the U.S. Department of Veterans Affairs, the NIH BRAIN Initiative/NINDS, NIDCD, and philanthropies including the ALS Association, the Movement Disorder Foundation and the Cerebral Palsy Alliance Research Foundation.
Dr. Daniel Ruben, MD, is Neurologist of MGH and one of the investigators for the BrainGate Clinical Trial. He has a scientific background in computational neuroscience and completed his clinical training in neurology and neurocritical care at Massachusetts General Hospital and Brigham and Women’s Hospital in Boston, MA
Join us everythingals.org/events
About the Event
everythingals.org/event-details/braingate-toward-the-restoration-of-communication-and-mobility-for-people-with-als
We are excited to host EverythingALS Community Event: BrainGate: Toward the restoration of communication and mobility for people with ALS.
Our speaker Dr. Leigh R. Hochberg, Neurologist at MGH and directs Center for Neurotechnology and Neurorecovery at MGH. He is joined by Dr. Daniel Ruben, Neurologist of MGH and one of the investigators for the BrainGate Clinical Trial.
Leigh R. Hochberg, MD, PhD is Professor of Engineering, School of Engineering and Carney Institute for Brain Science, Brown University; Director, VA RR&D Center for Neurorestoration and Neurotechnology (CfNN), Providence VAMC; Neurologist at Massachusetts General Hospital, where he attends in the NeuroICU and on the Acute Stroke service; and Senior Lecturer on Neurology at Harvard Medical School. He also directs the Center for Neurotechnology and Neurorecovery at MGH, and is the IDE Sponsor-Investigator and Principal Investigator of the BrainGate clinical trials, conducted by a close collaboration of scientists and clinicians at Brown, Case Western Reserve, MGH, Providence VAMC, and Stanford. Dr. Hochberg’s research focuses on the development and testing of novel neurotechnologies to help people with paralysis and other neurologic disorders. Dr. Hochberg and his research with the collaborative BrainGate team have been honored with the Joseph Martin Prize in Basic Research, the Herbert Pardes Prize for Excellence in Clinical Research, the first Israel Brain Technologies international B.R.A.I.N. Prize, presented by President Shimon Peres, and the Derek Denny-Brown Young Neurological Scholar Award. Dr. Hochberg’s BrainGate research, which has been published Nature, Lancet, Science Translational Medicine, eLife, Nature Medicine, Nature Neuroscience, the Journal of Neuroscience, the Journal of Neural Engineering, and others, is supported by the Rehabilitation R&D Service of the U.S. Department of Veterans Affairs, the NIH BRAIN Initiative/NINDS, NIDCD, and philanthropies including the ALS Association, the Movement Disorder Foundation and the Cerebral Palsy Alliance Research Foundation.
Dr. Daniel Ruben, MD, is Neurologist of MGH and one of the investigators for the BrainGate Clinical Trial. He has a scientific background in computational neuroscience and completed his clinical training in neurology and neurocritical care at Massachusetts General Hospital and Brigham and Women’s Hospital in Boston, MA
Join us everythingals.org/events
